Guanfacine
Guanfacine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Guanfacine; Generic name: GUANFACINE; Manufacturer: NORTHSTAR RXLLC.
| Brand name | Guanfacine |
|---|---|
| Generic name | GUANFACINE |
| Manufacturer | NORTHSTAR RXLLC |
| Used for | 1 INDICATIONS AND USAGE Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)] . Guanfacine extended-release tablets are a central alpha2A-adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications (1, 14). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Recommended dose: 1 mg to 7 mg (0.05 to 0.12 mg/kg target weight based dose range) once daily in the morning or evening based on clinical response and tolerability (2.2). Begin at a dose of 1 mg once daily and adjust in increments of no more than 1 mg/week (2.2). Do not crush, chew or break tablets before swallowing (2.1). Do not administer with high-fat meals, because of increased exposure (2.1). Do not substitute for immediate-release guanfacine tablets on a mg-per- |
| Active ingredient(s) | GUANFACINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b2afdab-8c92-463e-9734-f2c8b4200777 |